Related Experiment Video
Updated: Jun 19, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Oxidative stress markers and C-reactive protein in pediatric patients on hemodialysis
Manal F Elshamaa1, Samar Sabry, Mohamed Nabih
1Department of Pediatrics, National Research Center, Elbehoos Street, Dokki, Cairo, Egypt. manal_elshmaa@hotmail.com
Insights
Children on hemodialysis (HD) experience increased oxidative stress and inflammation, indicated by higher malondialdehyde (MDA) and high-sensitivity C-reactive protein (hsCRP) levels. These markers correlate with cardiovascular risks in pediatric patients.
Area of Science:
- Pediatric Nephrology
- Cardiovascular Health
- Oxidative Stress Research
Background:
- Children with end-stage renal disease on hemodialysis (HD) face significant oxidative stress.
- This imbalance impairs antioxidant defenses and elevates oxidative stress markers, contributing to inflammation.
Purpose of the Study:
- To compare plasma total antioxidant capacity (TAC) and lipid peroxidation products (MDA) in pediatric HD patients versus healthy controls.
- To investigate the relationship between these oxidative stress markers and high-sensitivity C-reactive protein (hsCRP) in pediatric HD patients.
Main Methods:
- Plasma TAC, MDA, and hsCRP levels were measured in 30 pediatric HD patients and 20 healthy controls (HC).
Main Results:
- Pediatric HD patients exhibited significantly higher TAC, MDA, and hsCRP levels compared to HC.
- A positive correlation was observed between TAC and hsCRP, and MDA and hsCRP in HD patients.
Conclusions:
- Children on HD show elevated oxidative stress, with MDA levels strongly linked to this susceptibility.
- Increased hsCRP in HD patients signifies heightened inflammatory activity, potentially explaining cardiovascular complications.
Background:
Pediatric patients with end-stage renal disease undergoing hemodialysis (HD) are exposed to oxidative stress associated with an impairment of antioxidant defense and an overproduction of oxidative stress markers. Oxidative stress plays a significant role in the development of inflammation in these patients.
Objectives:
The high incidence of cardiovascular disease in HD pediatric patients is now well established and the involvement of oxidative stress has been hypothesized. This study focuses on a comparison of plasma total antioxidant capacity (TAC) and lipid peroxidation product and evaluates the relationship between these parameters and high-sensitivity C-reactive protein (hsCRP) in pediatric patients on HD.
Subjects And Methods:
Plasma TAC, lipid peroxidation products, malondialdehyde (MDA) as well as hsCRP were determined in 30 pediatric patients on HD and in 20 healthy controls (HC).
Results:
TAC and MDA levels were significantly higher in children on HD than in the HC (p < 0.001). The hsCRP values were also significantly higher in HD patients than in HC (p < 0.001). The percentage of HD pediatric patients with CRP >10 mg/l was 30%. The concentrations of TAC and MDA correlated positively with hsCRP in HD patients (TAC: r = 0.52, p < 0.08; MDA: r = 0.75, p < 0.04), but not in HC.
Conclusion:
Our study demonstrates an increase in oxidative stress in children on HD and that the susceptibility to oxidative stress is strongly related to the levels of MDA produced in plasma. hsCRP levels are higher in children on HD than in HC and this is indicative of a higher degree of inflammatory activity in the former patients. These profound disturbances in oxidative stress markers may provide an explanation for the cardiovascular complications in HD patients.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease II: Clinical Manifestations
Acute Kidney Injury V: Interprofessional Care
Chronic Kidney Disease III: Interprofessional Care
Continuous Renal Replacement Therapy

